Han et al. found that BMSCs from both healthy individuals and those with CML increased the anti-apoptotic ability of cancer cells through regulation of Bcl-2, Bax, caspase-3, and activation of the Wnt signalling pathway in CML patients [94]. This evidence concerns the gene BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive.